Org 26576

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2011
01220052011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Brain derived neurotrophic factor (BDNF) is a key mediator of brain plasticity. The modulation of its expression and function is… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
BACKGROUND It has been posited that glutamate dysregulation contributes to the pathophysiology of attention-deficit/hyperactivity… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
Org 26576 acts by modulating ionotropic AMPA-type glutamate receptors to enhance glutamatergic neurotransmission. The aim of this… (More)
Is this relevant?
2012
2012
BACKGROUND A key challenge to dose selection in early central nervous system (CNS) clinical drug development is that patient… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • table III
Is this relevant?
2011
2011
The α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor potentiator Org 26576 represents an interesting… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2009
2009
Currently available antidepressants upregulate hippocampal neurogenesis and prefrontal gliogenesis after chronic administration… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Ampakines have shown beneficial effects on cognition in selected animal models of learning. However, their ability to modify long… (More)
Is this relevant?
2005
2005
AMPA receptor potentiating drugs (e.g. ampakines) enhance glutamatergic neurotransmission, and may have potential therapeutic… (More)
Is this relevant?